Co-crystal of dapagliflozin with citric acid

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9676741
SERIAL NO

15321007

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a dapagliflozin-citric acid co-crystal, processes for its preparation, and its use for the treatment of type 2 diabetes mellitus. A dapagliflozin citric acid co-crystal. The dapagliflozin citric acid co-crystal of claim 1, characterized by X-ray powder diffraction peaks having d-spacing values at about 3.89, 3.90, 4.01, 4.35, 5.77, and 5.80.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SUN PHARMACEUTICAL INDUSTRIES LIMITEDSUN HOUSE PLOT NO 201 B/1 STREET WESTERN EXPRESS HIGHWAY MUMBAI 400063 400063

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Prasad, Mohan Gurgaon, IN 105 94
Santra, Ramkinkar Paschim Medinipur, IN 3 8
Singh, Tarun Kumar Lucknow, IN 5 10
Thaimattam, Ram Hyderabad, IN 21 15

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 13, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 13, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00